Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 6, 2002, Pages 1074-1083

  Verma, Subodh ^a   Maitland, Andrew ^a   Weisel, Richard D ^a   Fedak, Paul W M ^a   Pomroy, Neil C ^a   Li, Shu Hong ^a   Mickle, Donald A G ^a   Li, Ren Ke ^a   Rao, Vivek ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; BUTANOL; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION INJURY; SIMULATION; SPECTROPHOTOMETRY; VASODILATATION;

EID: 0036622464     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.121687     Document Type: Article

References (29)

1. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol. 2001;281:H981-6.
2. Verma S, Lovren F, Dumont AS, Mather K, Maitland A, Kieser TM, et al. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg. 2000;120:668-71.
3. Schmid RA, Hillinger S, Walter R, Zollinger A, Stammberger U, Speich R, et al. The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg. 1999;118:726-32.
4. Jiang J, Valen G, Tokuno S, Thoren P, Pernow J. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin. Br J Pharmacol. 2000;131:1255-61.
5. Hillinger S, Sandera P, Carboni GL, Stammberger U, Zalunardo M, Schoedon G. et al. Survival and graft function in a large animal lung transplant model after 30 h preservation and substitution of the nitric oxide pathway. Eur J Cardiothorac Surg. 2001;20:508-13.
6. Ohkawa H, Ohishi N, Yahi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979:95:351-8.
7. 1-adrenoceptor mRNA. J Pharmacol Exp Ther. 2000;294:722-7.
8. Tumiati LC. Mickle DAG, Weisel RD, Williams WG, Li RK. An in-vitro model to study myocardial ischemic injury. J Tissue Cult Methods. 1994:16:1-9.
9. Ikonomidis JS, Tumiati LC, Weisel RD, Mickle DAG, Li RK. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc Res. 1994;28:1285-91.
10. Kokita N, Hara A. Abiko Y, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemia-reperfused isolated rat hearts. Anesth Analg. 1998;86:252-8.
11. Ozden A, Aybek Z, Saydam N, Calli N, Sauda, O, Duzcan E, et al. Cytoprotective effect of trimentazidine on 75 min renal ischemia-reperfusion injury in rats. Eur Surg Res. 1998;30:227-34.
12. Cosentino F, Barker JE. Brand MP. Heales SJ, Werner ER, Tippins JR, et al. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:496-502.
13. Weurocj AS. Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86:279-88.
14. Sato K, Zhao ZQ, McGee DS, Williams MW, Hammon JW, Vinten-Johansen J. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional post-ischemic injury. J Thorac Cardiovasc Surg. 1995:110:302-14.
15. Shiono N, Rao V, Weisel RD, Kawasak M, Li RK, Mickle DAG, et al. Effects of L-arginine in a human heart cell model of ischemia and reperfusion. Am J Physiol. 2002;282:H805-15.
16. Carden DL, Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol. 2000;190:255-66.
17. Banda MA, Lefer DJ, Granger DN. Postischemic endothelium-dependent vasodilatation is preserved in adhesion molecule deficient mice. Am J Physiol. 1997;273:H2721-5.
18. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100:2153-7.
19. Granger DN. Physiology and pathophysiology of the microcirculation. Prog Cardiovasc Med. 1998;3:123-40.
20. Pou S, Pou WS, Bredt DS, Synder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992;267:24173-6.
21. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BSS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthases: the influence of cofactors. Proc Natl Acad Sci U S A. 1998:95:9220-5.
22. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 1995;91:139-44.
23. Heinzel B, John M. Klatt P. Bohme E, Mayer B. Ca+ +/calmodulin dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 1992;2811627-30.
24. Kinoshita H, Milstein S, Wambi C, Katusic ZA. Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar arteries. Am J Physiol. 1997:42:H718-24.
25. Walter R, Blau N, Schaffner A, Schneemann M, Speich R, Stocker R. et al. Inhalation of nitric oxide cofactor tetrahydrobiopterin in health volunteers. Am J Respir Crit Care Med. 1997;156:2006-10.
26. Hayashida N, Weisel RD, Shirai T, Ikonomidis JS, Ivanov J, Carson SM, et al. Tepid antegrade and retrograde cardioplegia. Ann Thorac Surg. 1995;59:723-9.
27. Hayashida N, Ikonomidis JS, Weisel RD, Shirai T, Ivanov J, Carson S, et al. Adequate distribution of warm cardioplegic solution. J Thorac Cardiovasc Surg. 1995;110:800-12.
28. Shirai T. Rao V, Weisel RD, Ikonomidis JS Hayashida N, Ivanov J, et al. Antegrade and retrograde cardioplegia: simultaneous or alternate? J Thorac Cardiovasc Surg. 1996;112:787-96.
29. McDonald JD, Bode VC. Hyperphenylalaninemia is the hph-1 mouse mutant. Pediatr Res. 1988;23:63-7.